Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Affiliation to Social Security~* CRPS (complex regional pain syndrome) type I or II defined by the criteria of Bruehl (Table 1)~* CRPS of the upper limb including the wrist and / or hand~* CRPS post-surgical or post-traumatic~* Average pain in the last 24 hours of intensity \> = 30/100 on EVA (0 no pain, 100: worst pain imaginable )~* Evolution for over 3 months and less than 2 years~* Patients taking a stable background therapy for 15 days and not having received the following treatments in the previous months : bisphosphonate cure, infiltration, Qutenza, ketamine infusions~* Patients accepting a rehabilitation (physiotherapists or hospital units for patients included on Saint-Etienne and hospital units for patients included in Lyon and Saint- Vallier)~Exclusion Criteria:~* CRPS post stroke or drug~* Adhesive capsulitis isolated~* Cognitive or language difficulties preventing understanding instructions and / or a correct clinical evaluation~* Patient who already received a rehabilitation program with the use of mirror therapy or other virtual reality technology~* CRPS in connection with an accident caused by a third party for which a legal procedure is underway~* Major Depressive Episode~* Dissociative Disorders~* Visually impaired patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Experimental group : Mirror Therapy (Type: EXPERIMENTAL): Experimental group will perform mirror therapies during 16 weeks, added to the usual care. Therapy mirror sessions will take place at hospital units but also at home.
- Control group : Usual care (Type: ACTIVE_COMPARATOR): The control group will benefit from the usual care during 16 weeks. No mirror therapies will be performed to this group.

Based on this trial design, predict the completion outcome and termination type (if applicable).